IMU 0.94% 5.4¢ imugene limited

Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx, page-50

  1. 1,308 Posts.
    lightbulb Created with Sketch. 42
    Going through the information sheets on both IMU website and the link provided, same document, I see that there were 22 enrolled in this PH1 trial. We have one with zero tumors, an excellent result for this person, however I can find no results or information on the outcome for the other 21 , assuming that 22 finished the trial. Maybe I am not looking hard enough . Anyone see more information.

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.4¢
Change
0.001(0.94%)
Mkt cap ! $405.3M
Open High Low Value Volume
5.3¢ 5.5¢ 5.3¢ $307.9K 5.730M

Buyers (Bids)

No. Vol. Price($)
39 4724410 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.4¢ 1425268 24
View Market Depth
Last trade - 11.50am 11/09/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.